Cargando…

Lumbrokinase/paclitaxel nanoparticle complex: potential therapeutic applications in bladder cancer

BACKGROUND: Lumbrokinase (LK) is an enzyme complex with antithrombotic, antioxidant, antitumor, and immunomodulatory effects. It has been extensively studied and used in clinical anti-tumor therapy. However, its half-life is short, its bioavailability is low, and its toxicity and side effects are gr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Bo, Yan, Ying, Tong, Fei, Xu, Long, Zhu, Jia, Xu, Guangtao, Shen, Ruilin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6027826/ https://www.ncbi.nlm.nih.gov/pubmed/29983558 http://dx.doi.org/10.2147/IJN.S166438

Ejemplares similares

Recombinant Protein Production of Earthworm Lumbrokinase for Potential Antithrombotic Application
por: Wang, Kevin Yueju, et al.
Publicado: (2013)

Synthesis and evaluation of cationic polymeric micelles as carriers of lumbrokinase for targeted thrombolysis
por: Pan, Yang, et al.
Publicado: (2019)

The thrombolytic effect of lumbrokinase is not as potent as urokinase in a rabbit cerebral embolism model.
por: Kim, J. S., et al.
Publicado: (1993)

Lumbrokinase effects on pro- and anti-apoptotic gene expression in Wistar rats with testicular torsion
por: Danarto, Raden, et al.
Publicado: (2019)

PEG-b-(PELG-g-PLL) nanoparticles as TNF-α nanocarriers: potential cerebral ischemia/reperfusion injury therapeutic applications
por: Xu, Guangtao, et al.
Publicado: (2017)

Sirt1 Activation by Post-ischemic Treatment With Lumbrokinase Protects Against Myocardial Ischemia-Reperfusion Injury
por: Wang, Yi-Hsin, et al.
Publicado: (2018)

Bioactive protein fraction DLBS1033 containing lumbrokinase isolated from Lumbricus rubellus: ex vivo, in vivo, and pharmaceutic studies
por: Tjandrawinata, Raymond R, et al.
Publicado: (2014)

Efficacy and safety of lumbrokinase plus aspirin versus aspirin alone for acute ischemic stroke (LUCENT): study protocol for a multicenter randomized controlled trial
por: Chen, Ying, et al.
Publicado: (2022)

Ex Vivo Model to Evaluate the Antibacterial and Anti-Inflammatory Effects of Gelatin–Tricalcium Phosphate Composite Incorporated with Emodin and Lumbrokinase for Bone Regeneration
por: Wang, Wen-Ling, et al.
Publicado: (2023)

Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel
por: Liu, Yongjin, et al.
Publicado: (2011)

Self-assembled peptide-paclitaxel nanoparticles for enhancing therapeutic efficacy in colorectal cancer
por: Hou, Lidan, et al.
Publicado: (2022)

Transient Expression of Lumbrokinase (PI239) in Tobacco (Nicotiana tabacum) Using a Geminivirus-Based Single Replicon System Dissolves Fibrin and Blood Clots
por: Dickey, Alexia, et al.
Publicado: (2017)

Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma
por: Hassan, Md Sazzad, et al.
Publicado: (2018)

Lumbrokinase, a Fibrinolytic Enzyme, Prevents Intra-Abdominal Adhesion by Inhibiting the Migrative and Adhesive Activities of Fibroblast via Attenuation of the AP-1/ICAM-1 Signaling Pathway
por: Nguyen, Que Thanh Thanh, et al.
Publicado: (2023)

Application of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cells
por: Wu, Chao, et al.
Publicado: (2017)

The synergic antitumor effects of paclitaxel and temozolomide co-loaded in mPEG-PLGA nanoparticles on glioblastoma cells
por: Xu, Yuanyuan, et al.
Publicado: (2016)

Review: Application of Nanoparticles in Urothelial Cancer of the Urinary Bladder
por: Chen, Chieh-Hsiao, et al.
Publicado: (2015)

Use of oral paclitaxel for the treatment of bladder tumors in dogs
por: CHAE, Hyung-Kyu, et al.
Publicado: (2020)

Superior antitumor effect of self-assembly supramolecular paclitaxel nanoparticles
por: Yu, Na, et al.
Publicado: (2020)

Potentially Overestimated Efficacy of Nanoparticle Albumin-bound Paclitaxel compared with Solvent-based Paclitaxel in Breast Cancer: A Systemic Review and Meta-analysis
por: Li, Bing-Xue, et al.
Publicado: (2021)

Exploring the potential of functional polymer-lipid hybrid nanoparticles for enhanced oral delivery of paclitaxel
por: Qin, Lu, et al.
Publicado: (2021)

Novel free paclitaxel-loaded poly(L-γ-glutamylglutamine)–paclitaxel nanoparticles
por: Yang, Danbo, et al.
Publicado: (2011)

DNA topoisomerase IIα and RAD21 cohesin complex component are predicted as potential therapeutic targets in bladder cancer
por: Yu, Zhiling, et al.
Publicado: (2019)

Outcomes of seromuscular bladder augmentation compared with standard bladder augmentation in the treatment of children with neurogenic bladder
por: Sun, Xiao-Gang, et al.
Publicado: (2022)

A therapeutic agent of ursolic acid demonstrates potential application in aquaculture
por: Li, Bo-Yang, et al.
Publicado: (2022)

Reduction-responsive supramolecular hybridized paclitaxel nanoparticles for tumor treatment
por: Wang, Yuhan, et al.
Publicado: (2023)

Synthesis of Paclitaxel Derivatives for Remote Loading into Liposomes and Improved Therapeutic Effect
por: Xu, Xiangwei, et al.
Publicado: (2022)

Pure paclitaxel nanoparticles: preparation, characterization, and antitumor effect for human liver cancer SMMC-7721 cells
por: Wu, Chao, et al.
Publicado: (2018)

HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel
por: Lyu, Hui, et al.
Publicado: (2023)

Association between acute kidney injury and prognoses of cardiac surgery patients: Analysis of the MIMIC-III database
por: Sun, Chun, et al.
Publicado: (2023)

Circadian clock protein CRY1 prevents paclitaxel-induced senescence of bladder cancer cells by promoting p53 degradation
por: Jia, Min, et al.
Publicado: (2021)

In vivo synergistic anti-tumor effect of paclitaxel nanoparticles combined with radiotherapy on human cervical carcinoma
por: Yu, YanXin, et al.
Publicado: (2017)

Targeted Delivery of Paclitaxel in Liver Cancer Using Hyaluronic Acid Functionalized Mesoporous Hollow Alumina Nanoparticles
por: Gao, Yu, et al.
Publicado: (2019)

M1 macrophage-derived exosomes synergistically enhance the anti- bladder cancer effect of gemcitabine
por: Tang, Zhiling, et al.
Publicado: (2022)

Paclitaxel-loaded biodegradable ROS-sensitive nanoparticles for cancer therapy
por: Pandya, Abhilash D, et al.
Publicado: (2019)

Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration
por: Chen, Nianhang, et al.
Publicado: (2015)

Gold nanoparticle-mediated delivery of paclitaxel and nucleic acids for cancer therapy
por: Wang, Zhiguang, et al.
Publicado: (2020)

Evaluation of poly (lactic-co-glycolic acid) nanoparticles to improve the therapeutic efficacy of paclitaxel in breast cancer
por: Cabeza, Laura, et al.
Publicado: (2022)

Efficacy and safety of liposome-paclitaxel/liposome-paclitaxel combined with S-1 in 17 advanced gastric cancer patients with poor performance status
por: Wu, Runhong, et al.
Publicado: (2019)

Tumor suppressor genes and their underlying interactions in paclitaxel resistance in cancer therapy
por: Xu, Jia-Hui, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_idif5glet2265cr6inesvledbh